Myelodysplastic/myeloproliferative neoplasms: a disease in need of recognition.
Department of Leukemia, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Maliha
M
Khan
Department of Internal Medicine, Aga Khan University Medical College, Stadium Rd, Karachi 74800, Pakistan.
Maryam
M
Sarfraz
Department of Leukemia, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Naval
N
Daver
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D044127:Epigenesis, Genetic; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006801:Humans; D058990:Molecular Targeted Therapy; D054437:Myelodysplastic-Myeloproliferative Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D009196:Myeloproliferative Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics
D000970:Antineoplastic Agents
chronic myelomonocytic leukemia; myelodysplastic/myeloproliferative neoplasms; ruxolitinib